Replies to post #431991 on Amarin Corp Plc (AMRN)

[Number sleven]

JRoon, They also developed and patented a fixed dose combination. They even conducted a phase one study. (AMR-102) Until we have information that the company is going to commercialize these products, we shouldn't over value their importance. It's possible that they have applied for these patents in order to block competition. That is not an uncommon practice. When we discuss things that relate to this investment, I think it's important to delineate what we know from what we think.
Sleven,